SPAC6C3.08 Antibody

What is the SPAC6C3.08 Antibody and what organism does it target?

SPAC6C3.08 Antibody is a polyclonal antibody raised in rabbit that specifically targets the SPAC6C3.08 protein from Schizosaccharomyces pombe (strain 972/ATCC 24843), commonly known as fission yeast. The antibody is antigen affinity-purified and designed to recognize specific epitopes of the target protein. The immunogen used for antibody production is a recombinant Schizosaccharomyces pombe SPAC6C3.08 protein . This antibody represents an important tool for studying protein expression and function in fission yeast models, which are widely used in cell cycle and molecular biology research.

What are the validated applications for SPAC6C3.08 Antibody?

The SPAC6C3.08 Antibody has been validated for Western Blotting (WB) and Enzyme-Linked Immunosorbent Assay (ELISA) applications. When using this antibody for Western blotting, it's crucial to ensure proper identification of the antigen through appropriate controls and optimization of experimental conditions. The antibody is delivered in liquid form with non-conjugated format, allowing flexibility in detection methods depending on your specific experimental needs . Unlike some antibodies that are validated across numerous applications, the current validation data for SPAC6C3.08 Antibody focuses on these two primary techniques, making them the most reliable applications for research purposes.

How should I optimize Western blot conditions for SPAC6C3.08 Antibody?

Optimizing Western blot conditions for SPAC6C3.08 Antibody requires systematic testing of several parameters:

• Sample preparation: For fission yeast proteins, use a lysis buffer containing protease inhibitors to preserve protein integrity. Consider methods similar to those used for caspase detection, which often include detergent-based lysis buffers with protease inhibitors .

• Blocking and antibody dilution: Start with a 1:1000 dilution in 5% non-fat milk or BSA in TBST. The antibody is stored in a buffer containing 50% glycerol and 0.01M PBS at pH 7.4 , so ensure your dilution buffer is compatible.

• Incubation time and temperature: Begin with overnight incubation at 4°C for primary antibody and 1-2 hours at room temperature for secondary antibody.

• Detection method: Since the antibody is non-conjugated , select an appropriate species-specific secondary antibody (anti-rabbit) conjugated to your preferred detection system (HRP, fluorescent tag, etc.).

• Controls: Include both positive controls (known SPAC6C3.08-expressing samples) and negative controls (samples where the protein is absent or knocked out), similar to the validation approach used for other antibodies like caspase-8 .

Systematic optimization through factorial design experiments will help identify the ideal conditions for your specific experimental system.

What are the recommended protocols for antibody storage and handling to maintain efficacy?

To maintain optimal antibody performance, follow these evidence-based storage and handling recommendations:

• Storage temperature: Store the SPAC6C3.08 Antibody at -20°C or -80°C upon receipt . The lower temperature (-80°C) is preferable for long-term storage.

• Aliquoting: Divide the antibody into small single-use aliquots to avoid repeated freeze-thaw cycles. Each freeze-thaw cycle can reduce antibody activity by approximately 10-15%.

• Thawing procedure: Thaw aliquots quickly at room temperature and then keep on ice while working. Return unused portion to -20°C or -80°C immediately.

• Working dilution stability: Diluted antibody should be prepared fresh on the day of use. If necessary, diluted antibody can be stored at 4°C for up to 24 hours.

• Avoid contamination: Use sterile techniques when handling the antibody to prevent microbial contamination.

• Buffer composition awareness: The antibody is supplied in a buffer containing 0.03% Proclin 300 as a preservative , which helps maintain stability but should be considered when designing experiments sensitive to preservatives.

Following these guidelines will help preserve antibody functionality and experimental reproducibility over time.

How can I address non-specific binding issues with SPAC6C3.08 Antibody?

Non-specific binding is a common challenge with polyclonal antibodies like SPAC6C3.08 Antibody. To address this issue:

• Optimize blocking conditions: Test different blocking agents (BSA, casein, commercial blocking buffers) and concentrations (3-5%) to reduce background.

• Increase washing stringency: Implement additional washing steps with higher salt concentration (up to 500 mM NaCl) in TBST.

• Titrate antibody concentration: Perform a dilution series (1:500, 1:1000, 1:2000, 1:5000) to identify the optimal concentration that maximizes specific signal while minimizing background.

• Pre-adsorption: Consider pre-adsorbing the antibody with non-target proteins from your sample to remove antibodies that might bind non-specifically.

• Validate specificity: Perform knockout or knockdown controls similar to those used for other antibodies like caspase-8, where parental and knockout cell lines are compared to confirm specificity .

• Cross-reactivity testing: Since this is a polyclonal antibody raised against S. pombe proteins , test for potential cross-reactivity with proteins from other species in your experimental system.

Implementing these strategies systematically can help distinguish true signals from artifacts and improve data reliability.

What control samples should be included when working with SPAC6C3.08 Antibody?

Including appropriate controls is crucial for interpreting results with SPAC6C3.08 Antibody:

• Positive control: Samples from wild-type S. pombe (strain 972/ATCC 24843) that express SPAC6C3.08 .

• Negative control:

  • SPAC6C3.08 knockout or deletion mutant S. pombe strains

  • Irrelevant samples from non-yeast species where the protein isn't present

  • Similar to the knockout control strategy used for caspase-8 antibody validation

• Loading control: Include detection of a housekeeping protein (e.g., GAPDH) to normalize for total protein loading.

• Secondary antibody-only control: Omit primary antibody to assess non-specific binding of secondary antibody.

• Peptide competition control: Pre-incubate antibody with excess immunizing peptide to confirm binding specificity.

• Isotype control: Include a non-specific rabbit IgG at the same concentration as your primary antibody to assess background.

These controls help establish the specificity of observed signals and ensure experimental rigor, similar to the approaches demonstrated in the validation of other antibodies like caspase-8 .

How can I adapt SPAC6C3.08 Antibody for fluorescence microscopy applications?

Although SPAC6C3.08 Antibody is primarily validated for Western blot and ELISA , adapting it for immunofluorescence microscopy requires careful optimization:

• Fixation method comparison: Test multiple fixation protocols:

  • 4% paraformaldehyde (10-15 minutes)

  • Methanol (-20°C, 10 minutes)

  • Methanol/acetone mixture (1:1)
    Compare signal intensity and specificity across methods.

• Permeabilization optimization: For yeast cells with cell walls, enzymatic digestion with zymolyase or lyticase followed by detergent permeabilization (0.1-0.5% Triton X-100) is recommended.

• Antibody concentration: Start with higher concentrations (1:100-1:500) than used for Western blot.

• Signal amplification: Consider using a biotin-streptavidin system or tyramide signal amplification to enhance signal detection.

• Secondary antibody selection: Choose high-quality fluorophore-conjugated anti-rabbit secondary antibodies with spectral properties compatible with your microscopy setup.

• Controls: Include samples expressing tagged versions of SPAC6C3.08 that can be detected with alternative methods (e.g., anti-GFP) to confirm localization patterns.

• Z-stack imaging: For yeast cells, collect multiple focal planes to capture the complete distribution of the target protein.

This methodical approach can help establish immunofluorescence protocols despite the antibody not being initially validated for this application.

What strategies can I use to correlate SPAC6C3.08 expression with functional outcomes in S. pombe?

To establish meaningful correlations between SPAC6C3.08 expression and functional outcomes:

• Expression modulation approaches:

  • Construct inducible expression systems (e.g., nmt1 promoter series)

  • CRISPR-Cas9 knockdown/knockout strategies

  • Overexpression using plasmid-based systems

• Temporal expression analysis:

  • Synchronize cell populations (e.g., nitrogen starvation, hydroxyurea block)

  • Sample at defined time points during cell cycle or stress response

  • Quantify protein levels using quantitative Western blotting with SPAC6C3.08 Antibody

• Correlation with phenotypic assays:

  • Growth rate measurements

  • Cell morphology analysis

  • Stress response assays

  • Cell cycle progression analysis by flow cytometry

• Protein interaction studies:

  • Immunoprecipitation using SPAC6C3.08 Antibody

  • Mass spectrometry analysis of co-precipitated proteins

  • Validation of interactions using reverse co-immunoprecipitation

• Localization studies: If adapted for immunofluorescence, correlate protein localization changes with functional outcomes.

This integrated approach allows researchers to establish causal relationships between SPAC6C3.08 expression levels and cellular phenotypes, providing insights into protein function.

How does the performance of SPAC6C3.08 Antibody compare with other S. pombe protein detection methods?

When comparing SPAC6C3.08 Antibody with alternative detection methods:

• Epitope tagging vs. antibody detection:

  Parameter	SPAC6C3.08 Antibody	Epitope Tagging (e.g., HA, FLAG)
  Detection specificity	Dependent on antibody quality	Highly specific when using validated tag antibodies
  Protein function	Detects native protein	May interfere with protein function
  Experimental setup	Simpler (no genetic manipulation)	Requires genetic modification
  Signal strength	Variable, may need optimization	Generally robust with established tags
  Cost considerations	Higher per experiment	Higher initial investment, lower per experiment

• Mass spectrometry vs. antibody-based detection:

  Parameter	SPAC6C3.08 Antibody	Mass Spectrometry
  Sensitivity	Moderate to high	Typically higher
  Specificity	Depends on antibody quality	Very high with proper controls
  Throughput	Lower	Higher
  Quantification	Semi-quantitative	Fully quantitative
  Post-translational modifications	Limited detection	Comprehensive detection

• RNA-based vs. protein-based detection:

  Parameter	SPAC6C3.08 Antibody	RT-qPCR/RNA-Seq
  Target	Protein	mRNA
  Correlation with function	Directly detects functional molecule	Indirect (assumes correlation with protein)
  Post-transcriptional regulation	Captures effects	Cannot detect
  Sample processing	More complex	Simpler
  Multiplexing	Limited	Extensive

This comparative analysis helps researchers select the most appropriate method based on their specific experimental questions and available resources.

How can I integrate SPAC6C3.08 Antibody data with other -omics approaches for comprehensive functional analysis?

Integrating antibody-based detection with multi-omics approaches provides a more comprehensive understanding of SPAC6C3.08 function:

• Transcriptomic integration:

  • Correlate protein levels detected by SPAC6C3.08 Antibody with mRNA expression from RNA-Seq

  • Identify discrepancies suggesting post-transcriptional regulation

  • Use RNA-Seq data to identify co-regulated genes for pathway analysis

• Proteomic integration:

  • Compare Western blot quantification with mass spectrometry-based proteomics

  • Use immunoprecipitation with SPAC6C3.08 Antibody followed by mass spectrometry to identify protein interaction networks

  • Cross-validate findings using databases like PLAbDab for similar proteins

• Metabolomic correlation:

  • Associate SPAC6C3.08 protein levels with metabolic profiles

  • Identify metabolic pathways potentially regulated by SPAC6C3.08

• Structural biology integration:

  • Use antibody-validated expression data to inform structural studies

  • Apply knowledge from antibody epitope mapping to understand functional domains

• Data visualization and analysis:

  • Employ multivariate statistical methods to identify correlations across datasets

  • Use dimensionality reduction techniques to visualize complex relationships

  • Implement machine learning approaches to predict functional relationships

• Database utilization:

  • Compare your findings with existing antibody databases like PLAbDab

  • Upload validated protocols to community resources

This integrated approach enables researchers to position SPAC6C3.08 within broader cellular networks and gain deeper insights into its functional role in S. pombe biology.

What are promising approaches for developing improved detection tools for SPAC6C3.08 beyond traditional antibodies?

Several cutting-edge technologies show promise for enhanced SPAC6C3.08 detection:

• Nanobody development:

  • Smaller than traditional antibodies (~15 kDa vs ~150 kDa)

  • Better tissue penetration and epitope accessibility

  • More stable under varying conditions

  • Potential for direct expression in cells for live imaging

• Aptamer technology:

  • DNA/RNA-based detection molecules

  • Can be evolved in vitro for high specificity

  • More stable than antibodies in various conditions

  • Renewable resource without batch variation

• CRISPR-based detection:

  • Tagging endogenous SPAC6C3.08 with fluorescent proteins

  • Utilizing CRISPR imaging (dCas9 fused to fluorescent proteins)

  • Preserves physiological expression levels and regulation

• Proximity labeling approaches:

  • BioID or TurboID fusions to identify proximal proteins

  • APEX2-based labeling for ultrastructural localization

  • Complementary to traditional antibody-based detection methods

• Bispecific detection tools:

  • Combining SPAC6C3.08 recognition with other targets

  • Utilizing design principles from bispecific antibody development

  • Enhanced specificity through dual epitope recognition

• Computational design approaches:

  • AI-driven antibody design for enhanced specificity

  • In silico epitope prediction to target unique regions

  • Leveraging databases like PLAbDab for design inspiration

These approaches represent the frontier of protein detection technology and may overcome current limitations of the SPAC6C3.08 Antibody in terms of specificity, sensitivity, and application range.

How can linker engineering principles be applied to develop more effective antibody tools for S. pombe proteins?

Applying linker engineering principles, as described in bispecific antibody research , to develop enhanced detection tools for S. pombe proteins:

• Linker composition optimization:

  • Hydrophilic sequences to prevent intercalation between domains

  • Glycine-serine motifs (G4S)n for flexibility and minimal immunogenicity

  • Strategic incorporation of charged residues (glutamic acid, lysine) to enhance solubility

  • Phage display selection for linkers optimized for specific antibodies

• Linker length considerations:

  • Adjustable lengths to control domain orientation and association

  • Shorter linkers (5-10 amino acids) to promote multivalent forms

  • Longer linkers (15-20 amino acids) to maintain independent domain function

  • Fine-tuning to achieve desired configurations for optimal SPAC6C3.08 detection

• Application to recombinant antibody formats:

  • Single-chain variable fragments (scFvs) with optimized linkers

  • Bispecific formats targeting SPAC6C3.08 and a secondary marker

  • Diabody or TandAb configurations for enhanced avidity

  • Fusion proteins combining antibody fragments with reporter enzymes

• Experimental validation approaches:

  • Systematic comparison of different linker designs

  • Assessment of specificity, sensitivity, and background

  • Structural characterization of optimal configurations

  • Functional testing in diverse applications beyond Western blot and ELISA

• Computational design assistance:

  • Molecular dynamics simulations to predict linker behavior

  • In silico screening of candidate linker designs

  • Integration with database information from PLAbDab

These advanced engineering principles could transform SPAC6C3.08 detection tools from simple antibodies to sophisticated molecular constructs with enhanced performance characteristics across multiple applications .